Virtual Reality in Reeducation : Application to Shoulder Affections

November 28, 2023 updated by: Camille Tooth, University of Liege

The Use of Virtual Reality in Shoulder Reeducation : Interests and Limits.

The objective of this study is to assess the interest and the efficiency of virtual reality in functional rehabilitation of shoulder pain and shoulder injuries. Participants will follow a 12-week rehabilitation program based either on exercises or on a program integrating virtual reality. Results obtained with classical rehabilitation will be compared with the one obtained virtual reality.

Study Overview

Detailed Description

Fifty people will be included in the study. Then, they were randomly separated in two groups : 25 people will do the "classical rehabilitation" and the other 25 will have a treatment with virtual reality.

Each group (virtual reality and "classical rehabilitation") is going to follow 12 weeks of rehabilitation, at a rate of 2x 30 minutes per week. In "virtual reality group", each session will be divided in two parts : 15 minutes of virtual reality exercises and 15 minutes of exercises from "classical program". Exercises suggested in the classical program have been chosen among evidence based exercises described in literature.

Before the beginning of rehabilitation sessions, participants will be assessed at the Laboratory of Human Motion Analysis of the University of Liege. At this place, EMG activity of periscapular muscles (upper trapezius, lower trapezius and serratus anterior) (Delsys Trigno) , 3D scapular kinematics (Codamotion) will be assessed on the painful side when doing shoulder elevations in sagittal and in frontal planes. Maximum isometric strength will also be assessed using handheld dynamometer (MicroFet2) in 3 different positions (SeatedU90°, SeatedU125°, Prone-v-thumbs up)

This first evaluation will be done after the 12 week of rehabilitation too, with the same method.

Participants will also have to complete Dash (Disability of the Arm, Shoulder and Hand) questionnaire 3 times during the study (at the beginning, at 6 weeks and at the end of the study). Moreover, pain score will be asked to participants at each rehabilitation session.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Liège
      • Liege, Liège, Belgium, 4000
        • University of Liège

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • unilateral scapular dyskinesis
  • positive scapular assistance test and positive resistance test
  • shoulder pain
  • ability to play sport despite shoulder pain
  • one or more positive tendinous tests

Exclusion criteria :

  • traumatic history of shoulder injury in the last 6 months
  • surgical history at shoulder or cervical location
  • scoliosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: classical rehabilitation group
scapular exercises will be done
Experimental: virtual reality group
Functional exercises will be done by virtual reality group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire
Time Frame: change from baseline at 12 weeks
Functional ability and quality of life will be assessed using this questionnaire, with a maximal score of 100
change from baseline at 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder pain
Time Frame: change from baseline at 12 weeks
Shoulder pain will be assessed, with a maximum score of 10 (0= no pain and 10= maximum pain)
change from baseline at 12 weeks
EMG activity
Time Frame: Change from baseline at 12 weeks
EMG activity of upper trapezius, lower trapezius and serratus anterior will be assessed using surface EMG
Change from baseline at 12 weeks
3D scapular motion
Time Frame: Change from baseline at 12 weeks
Scapular motion will be assessed when doing elevations in sagittal and frontal planes (in loaded and unloaded conditions)
Change from baseline at 12 weeks
Maximum voluntary isometric contraction
Time Frame: Change from baseline at 12 weeks
Maximum isometric strength will be assessed in 3 different positions (SeatedU90°, SeatedU125°, Prone-v-thumbs up) with handheld dynamometer
Change from baseline at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Camille Tooth, University of Liège

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Estimated)

August 30, 2024

Study Completion (Estimated)

August 31, 2024

Study Registration Dates

First Submitted

March 21, 2019

First Submitted That Met QC Criteria

August 22, 2019

First Posted (Actual)

August 28, 2019

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 002 (University of CT Health Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Pain

Clinical Trials on EBM rehabilitation exercises

3
Subscribe